Access! 2021 Recap: Day Two
All of us here today have the ability and the opportunity to change the lives of hundreds of millions of people, declared Dan Leonard, CEO of the Association for Accessible Medicines on May 27, the second day of Access!—AAM’s signature annual event. I am optimistic, his state of AAM address continued, because this industry has […]
Access! 2021 Recap: Day One
Access! 2021, the annual meeting of the Association for Accessible Medicines (AAM), took place May 26 and 27, bringing together health care and industry leaders from around the country and around the world. The virtual conference convened amidst a background of continued progress in the United States against the COVID-19 pandemic, and some global setbacks and […]
GRx+Biosims 2020 Recap: A Virtual Success
Even If You Missed the Event, You Can Still Gain Access Last month, the Association for Accessible Medicines held our third annual GRx+Biosims conference—the premier scientific and regulatory event for the U.S. generics and biosimilars industry. For the first time, the conference took place virtually, to minimize spread of COVID-19. View Tweet GRx+Biosims is one […]
GRx+Biosims 2019 Year 2: The Recap
The second annual GRx+Biosims conference brought together a range of experts and leaders around the most urgent issues facing our industry. A healthy contingent from the Food and Drug Administration (FDA) demonstrated a firm commitment on the part of regulators to communicate openly with the manufacturers of generic and biosimilar medicines. Uniformed members of the […]
Recap: Highlights From the First GRx+Biosims Conference
Last week, AAM launched a new event—and a new tradition. GRx+Biosims welcomed nearly 550 participants from government, industry and related sectors to Baltimore, Maryland for presentations, workshops and high-level dialogues about the dynamic landscape for generic and biosimilar drugs. Hosted at the Baltimore Hilton September 5-7, the event encompassed the full range of AAM’s mission […]
Access! 2017 Recap: Ramping Up for AAM’s 2018 Annual Meeting
Now that registration is open for the 2018 meeting, it seems like a good time to look back at the February 2017 conference. That is when the Association for Accessible Medicines (AAM) unveiled our new identity, shedding the name “Generic Pharmaceutical Association.” “The Association’s new identity will improve recognition of the generic and biosimilar medicines […]
Recap of Access! 2018 — Delivering on the Promise of Generics and Biosimilars (Part 3)
Access! 2018 gave AAM members and industry leaders the information and motivation to deliver on the promise of generics and biosimilars. Former U.S. Navy Seal Rob O’Neill gave an inspiring talk about how his military training and experience apply to everyday life and business. AAM presented O’Neill with a $10,000 check for his nonprofit Your […]
Recap of Access! 2018 — Chip’s Call to Action (Part 2)
Access! 2018 emphasized the power that member companies have when they work together for advocacy. “We are the underdogs,” President and CEO Chip Davis declared in his remarks. In the face of massive buyer consortiums and brand-name pharmaceutical manufacturers with far greater financial resources than AAM and its members as well as state and federal […]
Recap of Access! 2018 — Successes From the Past Year (Part 1)
More than 600 leaders in the field came together last week to celebrate the achievements of the generic and biosimilars industry and to ready themselves for the political and business challenges ahead. Following an introduction by Emmy-winning journalist John Donvan, Association for Accessible Medicines (AAM) board chair, Apotex President and CEO Jeff Watson, offered his […]
Recap: AAM’s FallTech Conference 2017
AAM’s Fall Tech Conference November 6 and 7 focused on Abbreviated New Drug Application (ANDA) review, GDUFA II enhancements, drug pricing, bioequivalence and data integrity were the main topics of AAM’s Fall Tech Conference. As you read this event recap of the educational conference, start looking ahead to our next annual Access! conference, February 12-14, […]
